PriceTarget Research
  • Home
  • Research
  • Alerts
  • About Us
  • Our Stock Ratings
  • Terms of Use
  • Privacy
  • Contact Us
News Ticker
  • [ August 5, 2022 ] Alert: Rating Upgrade (8/5/22)-TransUnion (NYSE: TRU). Up
  • [ August 5, 2022 ] Alert: Rating Upgrade (8/5/22)-Collegium Pharmaceutical Inc (NASDAQ: COLL). Up
  • [ August 5, 2022 ] Alert: Major Price Advance (8/5/22)-Coherus BioSciences Inc (NASDAQ: CHRS). Price Chg
  • [ August 5, 2022 ] Alert: Major Price Advance (8/5/22)-Rayonier Advanced Materials Inc (NYSE: RYAM). Price Chg
  • [ August 5, 2022 ] Alert: Rating Downgrade (8/5/22)-Minerva Neurosciences Inc (NASDAQ: NERV). Down
Up

Alert: Rating Upgrade (8/5/22)-TransUnion (NYSE: TRU).

August 5, 2022 John Lafferty 0

Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for TransUnion (NYSE: TRU) improved in recent days. TRU’s current Value Trend Rating is C and the prior Rating was D. […]

Up

Alert: Rating Upgrade (8/5/22)-Collegium Pharmaceutical Inc (NASDAQ: COLL).

August 5, 2022 John Lafferty 0

Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Collegium Pharmaceutical Inc (NASDAQ: COLL) rose significantly recently. COLL’s current Value Trend Rating is A and the prior Rating was […]

Price Chg

Alert: Major Price Advance (8/5/22)-Coherus BioSciences Inc (NASDAQ: CHRS).

August 5, 2022 John Lafferty 0

Coherus BioSciences Inc (NASDAQ: CHRS) stock closed at $11.83 on 8/5/22 after a major increase of 11.8%. Moreover, unusually high trading volume at 160% of normal accompanied the advance. The stock has risen 40.2% during […]

Price Chg

Alert: Major Price Advance (8/5/22)-Rayonier Advanced Materials Inc (NYSE: RYAM).

August 5, 2022 John Lafferty 0

Rayonier Advanced Materials Inc (NYSE: RYAM) stock enjoyed a major increase of 10.7% on 8/5/22. The shares closed at $4.76. NORMAL trading volume accompanied the advance. The stock has been extremely weak relative to the […]

Down

Alert: Rating Downgrade (8/5/22)-Minerva Neurosciences Inc (NASDAQ: NERV).

August 5, 2022 John Lafferty 0

Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Minerva Neurosciences Inc (NASDAQ: NERV) weakened of late. NERV’s current Value Trend Rating is D and the prior Rating was […]

Ratings

  • A (14,710)
  • B (19,646)
  • C (47,880)
  • D (17,483)
  • F (12,777)

Exchanges

  • NASDAQ
  • NYSE
  • NYSEAMERICAN
  • TSE
  • BATS
  • CVE

Industries

Sectors

  • Youtube
  • Facebook
  • Twitter
  • Terms of Use
  • Site Map
  • About Us
  • Privacy

Archives

  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
August 2022
M T W T F S S
« Jul    
1234567
891011121314
15161718192021
22232425262728
293031  

© 2019 PriceTarget Research